Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28697641
PubMed Central
PMC5675271
DOI
10.1177/1557988317714359
Knihovny.cz E-zdroje
- Klíčová slova
- acute myocardial infarction, atherosclerosis, erectile dysfunction, ischaemic heart disease,
- MeSH
- dospělí MeSH
- erektilní dysfunkce * epidemiologie psychologie MeSH
- infarkt myokardu * MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- přežívající * MeSH
- zdravotnické přehledy MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Erectile dysfunction significantly affects quality of life in young men. Authors have evaluated erectile function in men with coronary artery disease (CAD) and the relationship between the degree of erectile dysfunction (ED) and the age of their first acute myocardial infarction (AMI). The incidence of erectile dysfunction in three groups of patients of AMI survivors was investigated: AMI survivors younger than 45 years, AMI survivors older than 65 years, and normal male population aged between 30 and 60 years. Erectile function was assessed by the International Index of Erectile Function (IIEF-5) questionnaire. In post-AMI male patients younger than 45 years ( n = 76), mild ED occurred in 26% and severe in 7%. In the older AMI group, mild ED occurred in 52% and severe in 38%. In the control group age matched to younger survivors, 96% denied ED and only one control patient had a score of 20 on the IIEF-5. A paradoxical result was observed in patients using beta blockers (BB), who had better scores than the group without BB. Statin treatment had a positive influence on the score in questionnaires. Those on statins had an average score of 21.0 ± 4.9 vs. without statin 17.7 ± 5.7, p = .03. The current findings identified that the prevalence of ED is relatively high in young patients with CAD and is related to treatment of the CAD. The overall increase in ED presence suggests that the background of their coronary event is not due to destabilization of single focused atheroma but may reflect a generalized atherosclerotic process.
Zobrazit více v PubMed
Andersson D. P., Trolle Lagerros Y., Grotta A., Bellocco R., Lehtihet M., Holzmann M. J. (2017). Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction. Heart. doi:10.1136/heartjnl-2016-310746 PubMed DOI PMC
Borgquist R., Gudmundsson P., Winter R., Nilsson P., Willenheimer R. (2006). Erectile dysfunction in healthy subjects predicts reduced coronary flow velocity reserve. International Journal of Cardiology, 112(2), 166–170. doi:10.1016/j.ijcard.2005.08.035 PubMed DOI
Byrne M., Doherty S., Fridlund B. G., Martensson J., Steinke E. E., Jaarsma T., Devane D. (2016). Sexual counselling for sexual problems in patients with cardiovascular disease. The Cochrane Database of Systematic Reviews, (2), CD010988. doi:10.1002/14651858.CD010988.pub2 PubMed DOI PMC
Foroutan S. K., Rajabi M. (2007). Erectile dysfunction in men with angiographically documented coronary artery disease. Urology Journal, 4(1), 28–32. PubMed
Gandaglia G., Briganti A., Jackson G., Kloner R. A., Montorsi F., Montorsi P., Vlachopoulos C. (2014). A systematic review of the association between erectile dysfunction and cardiovascular disease. European Urology, 65(5), 968–978. doi:10.1016/j.eururo.2013.08.023 PubMed DOI
Linhart A., Dostalova G., Belohlavek J., Vitek L., Karetova D., Ingrischova M., . . .Cifkova R. (2012). Carotid intima-media thickness in young survivors of acute myocardial infarction. Experimental and Clinical Cardiology, 17(4), 215–220. PubMed PMC
Montorsi F., Briganti A., Salonia A., Rigatti P., Margonato A., Macchi A., . . .Montorsi P. (2003). Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. European Urology, 44(3), 360– 364; discussion 364–365. PubMed
Nascimento E. R., Maia A. C., Pereira V., Soares-Filho G., Nardi A. E., Silva A. C. (2013). Sexual dysfunction and cardiovascular diseases: A systematic review of prevalence. Clinics (Sao Paulo), 68(11), 1462–1468. doi:10.6061/clinics/2013(11)13 PubMed DOI PMC
NIH Consensus Conference. NIH Consensus Development Panel on Impotence. (1993). Impotence. The Journal of the American Medical Association, 270(1), 83–90. PubMed
Omland T., Randby A., Hrubos-Strom H., Rosjo H., Einvik G. (2016). Relation of erectile dysfunction to subclinical myocardial injury. The American Journal of Cardiology, 118(12), 1821–1825. doi:10.1016/j.amjcard.2016.08.070 PubMed DOI
Otunctemur A., Sahin S., Ozbek E., Cekmen M., Inal A., Tulubas F., . . .Koklu I. (2015). Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease. Andrologia, 47(6), 706–710. doi:10.1111/and.12322 PubMed DOI
Rhoden E. L., Teloken C., Sogari P. R., Vargas Souto C. A. (2002). The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. International Journal of Impotence Research, 14(4), 245–250. doi:10.1038/sj.ijir.3900859 PubMed DOI
Rosen R. C., Cappelleri J. C., Smith M. D., Lipsky J., Pena B. M. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research, 11(6), 319–326. PubMed
Thygesen K., Alpert J., Jaffe A., Simoons ML., Mendis S. (2012) Third Universal Definition o Myocardial Infarction Circulation. 2012;126:2020-2035 PubMed